High-Throughput In Vitro Assay using Patient-Derived Tumor OrganoidsArisa Higa 1, Nobuhiko Takahashi 2,3, Gen Hiyama 2, Hirosumi Tamura 2, Hirotaka Hoshi 2, Kenju Shimomura 3, Shinya Watanabe 2, Motoki Takagi 2
1FUJIFILM Wako Bio Solutions Corporation, 2Medical-Industrial Translational Research Center, Fukushima Medical University, 3Department of Bioregulation and Pharmacological Medicine, Fukushima Medical University
A highly accurate in vitro high-throughput assay system was developed to evaluate anticancer drugs using patient-derived tumor organoids (PDOs), similar to cancer tissues but are unsuitable for in vitro high-throughput assay systems with 96-well and 384-well plates.
